1056820531ENSG00000157765ENSMUSG00000029188O95436Q9DBP0NM_006424NM_001177998NM_001177999NM_011402NP_001171469NP_001171470NP_006415NP_035532Sodium-dependent phosphate transport protein 2B (NaPi2b) is a protein that in humans is encoded by the SLC34A2 gene.

[5][6][7] Sodium-dependent phosphate transport protein 2b (NaPi2b) is a tumor-associated antigen.

[8] As of April 2023, upifitamab rilsodotin, an antibody-drug conjugate (ADC) targeting NaPi2b, is in Phase 3 clinical trials for recurrent platinum-sensitive ovarian cancer.

[9] This membrane protein–related article is a stub.

You can help Wikipedia by expanding it.